The emerging approach of this peptide represents a significant development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide224836.tkzblog.com/41768145/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment